Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Martinez

Showing results (531-540 of 706) with videos related to

Pageof 71
Sort By:
European Neurology|July 14, 2021
Validation of the Finnish Version of the Unified Dyskinesia Rating ScaleValtteri Kaasinen, Filip Scheperjans, Mikko Kärppä, et al.
Brain Stimulation|April 16, 2018
Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contactsHaidar Salimi Dafsari, Jan Niklas Petry-Schmelzer, K Ray-Chaudhuri, et al.
Plos Neglected Tropical Diseases|September 12, 2022
Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB/c miceVictor Manuel Dzul-Huchim, Maria Jesus Ramirez-Sierra, Pedro Pablo Martinez-Vega, et al.
Neuroepidemiology|August 14, 2017
Non-Motor Symptoms Assessed by Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale in Parkinson's Disease in Selected Asian PopulationsAnna Sauerbier, Onanong Jitkritsadakul, Nataliya Titova, et al.
JTO Clinical and Research Reports|September 30, 2021
SPACEWALK: A Remote Participation Study of ALK Resistance Leveraging Plasma Cell-Free DNA GenotypingMarissa N Lawrence, Rubii M Tamen, Pablo Martinez, et al.
JAMA Network Open|January 18, 2024
Neurostimulation for Advanced Parkinson Disease and Quality of Life at 5 Years: A Nonrandomized Controlled TrialStefanie T Jost, Salima Aloui, Julian Evans, et al.
Neurobiology of Aging|November 13, 2015
Gray matter network disruptions and amyloid beta in cognitively normal adultsBetty M Tijms, Mara Ten Kate, Alle Meije Wink, et al.
Frontiers in Aging Neuroscience|August 9, 2021
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own StudiesLiu Shi, Noel J Buckley, Isabelle Bos, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 19, 2017
Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on ageHaidar S Dafsari, Paul Reker, Lisa Stalinski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2021
Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody-Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or EnzalutamideJohann S de Bono, Mark T Fleming, Judy S Wang, et al.
Pageof 71

Showing results (531-540 of 706) with videos related to

Sort By:
Pageof 71
European Neurology|July 14, 2021
Validation of the Finnish Version of the Unified Dyskinesia Rating ScaleValtteri Kaasinen, Filip Scheperjans, Mikko Kärppä, et al.
Brain Stimulation|April 16, 2018
Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contactsHaidar Salimi Dafsari, Jan Niklas Petry-Schmelzer, K Ray-Chaudhuri, et al.
Plos Neglected Tropical Diseases|September 12, 2022
Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB/c miceVictor Manuel Dzul-Huchim, Maria Jesus Ramirez-Sierra, Pedro Pablo Martinez-Vega, et al.
Neuroepidemiology|August 14, 2017
Non-Motor Symptoms Assessed by Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale in Parkinson's Disease in Selected Asian PopulationsAnna Sauerbier, Onanong Jitkritsadakul, Nataliya Titova, et al.
JTO Clinical and Research Reports|September 30, 2021
SPACEWALK: A Remote Participation Study of ALK Resistance Leveraging Plasma Cell-Free DNA GenotypingMarissa N Lawrence, Rubii M Tamen, Pablo Martinez, et al.
JAMA Network Open|January 18, 2024
Neurostimulation for Advanced Parkinson Disease and Quality of Life at 5 Years: A Nonrandomized Controlled TrialStefanie T Jost, Salima Aloui, Julian Evans, et al.
Neurobiology of Aging|November 13, 2015
Gray matter network disruptions and amyloid beta in cognitively normal adultsBetty M Tijms, Mara Ten Kate, Alle Meije Wink, et al.
Frontiers in Aging Neuroscience|August 9, 2021
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own StudiesLiu Shi, Noel J Buckley, Isabelle Bos, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 19, 2017
Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on ageHaidar S Dafsari, Paul Reker, Lisa Stalinski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2021
Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody-Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or EnzalutamideJohann S de Bono, Mark T Fleming, Judy S Wang, et al.
Pageof 71